Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
Although artificial intelligence (AI) has demonstrated potential in automating glaucoma screening, there is still a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results